Key facts
- The portion of growth companies in sectors like biotechnology and AI listed on Hong Kong's bourse has risen to 30% from 10% in 2023.
- Most growth companies are three to five years old, with some developing AI models.
Hong Kong has seen an increase in listings of growth companies, particularly in biotechnology and AI, due to improved market infrastructure and reforms, according to Julia Leung, CEO of the Securities and Futures Commission. The portion of such firms on the exchange has risen to 30% from 10% in 2023.

The reforms and increased listings of growth companies in Hong Kong, particularly in AI and biotech, signal the exchange's efforts to attract innovative firms and capital, potentially impacting the flow of investment into these sectors.
Hong Kong has seen an increase in listings of growth companies, those yet to achieve sustained profitability but with strong growth potential, due to improved market infrastructure and reforms, according to Julia Leung, CEO of its Securities and Futures Commission. Leung said during a seminar in Tokyo on Monday that the portion of growth companies in sectors like biotechnology and AI listed on the exchange has risen to 30% from 10% in 2023. She noted that the stock exchange has implemented proactive reforms to attract these firms, balancing investor protection with the entry of companies that have not fully commercialized their products. Most of these growth companies are three to five years old, with some developing AI models. Leung added that Hong Kong benefits from its proximity to China, a major producer in the AI supply chain, and that startups are seeking capital and international expansion.
Pick the topics you care about. Get only what matters, on your cadence.